praticoles

  The global non-alcoholic steatohepatitis biomarkers   market accounted for US$ 556.6 billion in 2019 and is estimated to be US$ 8177.9 billion by 2029 and is anticipated to register a CAGR of 31.3% The report  " Global   Non-alcoholic Steatohepatitis Biomarkers Market, By  Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers, and Others), By End-user (Pharma & CRO Industry, Hospitals, Diagnostic Labs, and Academic Research Institutes),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In January 2019, LabCorp. a leading global life sciences company, and GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases, announced the signing of a licensing agreement between GENFI...

Smart Lab Market accounted for US$ 4.1 billion in 2020 and is estimated to be US$ 6.84 billion by 2030 and is anticipated to register a CAGR of 5.30%. Smart Lab uses technology to automate or replace manual procedures and equipment manipulation. The degree of automation in a lab is determined by the workflow. The widespread use of automated instruments is most commonly seen at academic and research institutes in order to increase production and save time spent on different monotonous chores. Furthermore, the usage of automated tools by pharmaceutical companies' drug development departments is expected to significantly automate research phases, boosting market growth. The medical laboratory area has been altered by laboratory automation, which has steadily replaced semi-automatic and manual processes with completely automated equipment. The report   "   Global Smart Lab Market, By Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), By Application (Drug Discovery...